| Literature DB >> 30075002 |
Vincent Castiglione1, Pierre-Yves Sacré2, Etienne Cavalier1, Philippe Hubert2, Romy Gadisseur1, Eric Ziemons2.
Abstract
BACKGROUND AND OBJECTIVES: The kidney stone's structure might provide clinical information in addition to the stone composition. The Raman chemical imaging is a technology used for the production of two-dimension maps of the constituents' distribution in samples. We aimed at determining the use of Raman chemical imaging in urinary stone analysis.Entities:
Mesh:
Year: 2018 PMID: 30075002 PMCID: PMC6075768 DOI: 10.1371/journal.pone.0201460
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fourier Transform Infrared spectroscopy and Raman chemical imaging samples’ composition.
| Sample | Fourier transform infrared | Raman chemical imaging |
|---|---|---|
| 1 | Calcium oxalate monohydrate (100%) | Calcium oxalate monohydrate |
| 2 | Calcium oxalate monohydrate (60%) Ammonium urate (30%) Proteins (10%) | Calcium oxalate monohydrate Ammonium urate |
| 3 | Calcium oxalate dihydrate (80%) Calcium oxalate monohydrate (15%) Apatite (5%) | Calcium oxalate dihydrate Calcium oxalate monohydrate Apatite |
| 4 | Anhydrous uric acid (100%) | Anhydrous uric acid |
| 5 | Uric acid dihydrate (90%) Anhydrous uric acid (10%) | Uric acid dihydrate Anhydrous uric acid |
| 6 | Apatite (80%) Calcium oxalate monohydrate (20%) | Apatite Calcium oxalate monohydrate |
| 7 | Struvite (95%) Proteins (5%) | Struvite |
| 8 | Brushite (90%) Calcium oxalate dihydrate (10%) | Brushite Calcium oxalate dihydrate |
| 9 | Brushite (25%) Whitlockite (25%) Apatite (25%) Proteins (20%) Calcium oxalate dihydrate (5%) | Brushite Whitlockite Apatite Calcium oxalate dihydrate |
| 10 | Apatite (40%) Struvite (35%) Ammonium urate (20%) Calcium oxalate monohydrate (5%) | Apatite Struvite Ammonium urate Calcium oxalate monohydrate |
| 11 | Apatite (30%) Calcium oxalate dihydrate (20%) Calcium oxalate monohydrate (20%) Proteins (15%) Glycosaminoglycans (15%) | Apatite Calcium oxalate dihydrate Calcium oxalate monohydrate |
| 12 | Calcium oxalate monohydrate (80%) N-Acetyl-Sulfamethoxazole (20%) | Calcium oxalate monohydrate N-Acetyl-Sulfamethoxazole |
| 13 | Calcium oxalate monohydrate (100%) Triamterene and metabolites (traces) | Calcium oxalate monohydrate Apatite |
| 14 | Calcium oxalate monohydrate (70%) Atazanavir (30%). | Calcium oxalate monohydrate Atazanavir |
Struvite: magnesium ammonium phosphate (triple phosphate)
Fig 1Raman mapping of sample 3.
Raman mapping of the calcium oxalate dihydrate (A), calcium oxalate monohydrate (B) and apatite (C) and their correspondent Raman spectra. Step size: 50 μm. The yellow to dark blue scale represents the high density of a component or its absence. The peripheral spikes of the stones are mainly made of calcium oxalate dihydrate, while its center has turned into calcium oxalate monohydrate.
Fig 2Raman mapping of sample 9.
Raman mapping of whitlockite (A), calcium oxalate dihydrate (B), apatite (C), and brushite (D). Step size: 50 μm. The yellow to dark blue scale represents the high density of a component or its absence. The core of the stone was absent and provided low signal. The rest of the stone was made of whitlockite and apatite, probably due to former urinary tract infection, while the brushite coat is associated to recent hypercalciuria.
Fig 3Raman mapping of sample 12.
Raman mapping of calcium oxalate monohydrate with main absorption peak at 1487 (A) or at 1462 (B) and N-Acetyl-Sulfamethoxazole external deposit (C) and their correspondent Raman spectra. Step size: 5μm. The yellow to dark blue scale represents the high density of a component or its absence. The difference in main absorption peak of calcium oxalate monohydrate reveals a radial structure of the stone.